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Novel probe-level algorithms <p>A novel algorithm (ChipStat) is presented for detecting gene-expression changes from Affymetrix microarray data. The method is used  to identify changes in murine mammary development.</p>
Abstract
We describe a novel algorithm (ChipStat) for detecting gene-expression changes utilizing probe-
level comparisons of replicate Affymetrix oligonucleotide microarray data. A combined detection
approach is shown to yield greater sensitivity than a number of widely used methodologies
including SAM, dChip and logit-T. Using this approach, we identify alterations in functional pathways
during murine neonatal-pubertal mammary development that include the coordinate upregulation
of major urinary proteins and the downregulation of loci exhibiting reciprocal imprinting.
Background
The widespread use of DNA microarrays to measure tran-
script abundance from a significant fraction of the genome
has proven to be a valuable tool for identifying functional cel-
lular pathways as well as for capturing the global state of a
biological system [1-4]. These arrays have typically been con-
structed by spotting large, pre-synthesized strands of nucleic
acid on an appropriate surface [5] or by directly synthesizing
smaller oligonucleotides in situ at defined locations [6]. The
latter technique has been implemented in Affymetrix oligo-
nucleotide microarrays designed for expression analysis.
Because hybridization to short (25-mer) oligonucleotides is
used to measure expression, Affymetrix arrays contain multi-
ple, independent oligonucleotides designed to bind a unique
transcript. In this way, specificity and a high signal-to-noise
ratio can be maintained despite the noise due to the hybridi-
zation itself. When the intensity of hybridization to a given
oligonucleotide designed to detect the transcript (a 'perfect
match' probe, PM) is corrected by its corresponding (single
b a s e - p a i r  ' m i s m a t c h ' ,  M M )  c o n t r o l ,  a n  e s t i m a t e  o f  g e n e
expression (PM - MM) is derived. This probe pair value is
then combined with values from the other, independent, oli-
gonucleotides designed to bind the same transcript (together
designated the probe set) to obtain a more robust estimate of
transcript abundance [7].
The ability to sensitively detect changes in gene expression is
crucial for a transcript-level analysis of developmental proc-
esses and other processes involving changes in the relative
sizes of cellular compartments. Early attempts to limit the
false-positive rate of microarray studies focused on the mag-
nitude of fold-change in gene expression (see, for example
[1]). For studying purified cell populations, where a substan-
tial change in gene expression is more likely to reflect biolog-
ically relevant function, such a crude limitation was
acceptable. However, adequate studies of complex tissues
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require a substantially more sensitive method of detection.
For example, a small yet reproducible change in gene expres-
sion within a whole organ may reflect a substantial expansion
or regulatory change within a subpopulation of cells that
overexpress a given gene relative to the surrounding tissue.
Thus, a method for identifying such small, statistically signif-
icant changes in gene expression is required.
Because of the variety of techniques used to measure gene
expression, it has become commonplace to utilize simple,
numerical estimates of gene expression as the starting point
for such identification. One major drawback to this approach
has been that individual probe cell information from Affyme-
trix microarrays is routinely discarded. This issue has only
recently begun to be addressed [8-10], and it appears that a
substantial amount of useful information can be obtained
from probe-level analysis.
An additional compromise has been driven by the practical
difficulties of performing large numbers of microarray exper-
iments. Given limited samples, permutation of the existing
experimental dataset, rather than use of independent sets of
control samples, has been widely used to estimate the statis-
t i c a l  s i g n i f i c a n c e  o f  d i f f e r e n t i a l  g e n e  e x p r e s s i o n  [ 1 1 ] .
Although this technique has been useful given the historically
high cost of performing microarray analysis, it may inher-
ently limit the sensitivity of the results obtained. As such, a
test for differential gene expression that utilizes a 'gold stand-
ard' negative-control dataset would have clear advantages.
The impetus for the work described here is the desire to sen-
sitively identify coherent patterns of gene expression during
mammary gland development. At 2 weeks of age, the female
FVB mouse mammary gland exists as a rudimentary epithe-
lial tree embedded at one end of a fat pad composed of adi-
pose tissue and fibroblasts. Previous work has demonstrated
a fundamental transition in the composition of the mammary
adipose compartment from brown fat to white fat during
early development [4]. By 3 weeks of age, the onset of puberty
heralds the beginning of the process of ductal morphogenesis,
which results in the formation of the branching epithelial tree
of the adult gland. The onset of puberty results not only in the
rapid growth of a ductal epithelial tree but also the appear-
ance of specialized, highly proliferative structures known as
terminal end buds that elaborate this tree via branching mor-
phogenesis [12,13]. Furthermore, puberty is known to be a
time of increased susceptibility to carcinogenesis [14,15].
Thus, a detailed examination of transcriptional changes dur-
ing this period would be of substantial use.
We describe here a novel algorithm for sensitively detecting
gene-expression changes using information derived from
individual probe cell hybridizations to Affymetrix oligonucle-
otide microarrays. In addition to modeling the predicted
behavior of this algorithm, we have generated an independent
cohort of control samples derived from the murine mammary
gland that can be used to empirically calibrate its statistical
behavior. We have then used this algorithm to analyze a bio-
logical transition in early murine mammary gland develop-
ment in order to compare the sensitivity of this approach to
other commonly used algorithms. In conjunction with a sec-
ond novel algorithm, we have developed an aggregate
approach to the reliable detection of differential gene expres-
sion that yields substantially improved sensitivity across a
range of false-positive rates and have applied this approach to
the analysis of early murine mammary gland development.
Results
A variety of traditional statistical methods, such as the t test,
have been used in conjunction with microarray datasets to
detect changes in gene expression (see for example [16]).
Given the large numbers of genes tested, it is widely recog-
nized that a stringent threshold for statistical significance is
necessary in order to reduce the number of false positive
changes. For example, a threshold of statistical significance of
P < 0.001 would be expected to yield around 100 false posi-
tives on a typical array measuring 10,000 genes. Some algo-
rithms, such as significance analysis for microarrays (SAM)
[11], explicitly control the number of expected false-positive
results using permutations of the existing dataset. Regardless
of the method utilized, statistical differences are typically cal-
culated on the basis of an aggregate measure of gene expres-
sion (a gene signal). However, a fundamental difficulty with
these methods is that they often do not have the requisite sta-
tistical power to sensitively detect changes in gene expression
after correction for multiple hypothesis testing. We reasoned
that utilizing the multiple hybridizations to independent oli-
gonucleotides on the Affymetrix platform might allow us to
develop a method for detecting expression changes with sub-
stantially greater statistical power.
To test this approach, we developed a novel analytical algo-
rithm that is based on identifying individual differences at a
given statistical significance between corresponding probe
pairs. To a first approximation, the signal on any given probe
cell can be modeled as:
S = M + E(b) + E(p) + E(h), E ~ N
Where S is the signal detected on the microarray, M is the
average message level in a given experimental state, E(b) is
noise due to biological variation between animals or animal
pools, E(p) is the noise due to variations in sample measure-
ment, and E(h) is the noise inherent in hybridization to oligo-
nucleotide features on the array. The goal of our analysis was
to identify a method that would allow us to reliably distin-
guish significant differences in M under particular experi-
mental conditions.
Given this model, we reasoned that the relative magnitude of
E(b) + E(p) (the experimental noise) compared with E(h) (thehttp://genomebiology.com/2005/6/2/R20 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. R20.3
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hybridization noise) should determine whether comparisons
between individual probe pairs would be useful. If the bulk of
noise in our microarray data was due to factors influencing
the level of transcript available for measurement (that is, E(b)
+ E(p) >> E(h)), then individual probe-pair measurements
should only reflect the pre-hybridization bias in transcript
availability. In this case, the t-test or other measurement
based on the average of the probe set would be expected to
perform as well as an algorithm based on individual probe-
pair comparisons. In contrast, if most noise in the measure-
ment of true transcript level exists at the level of hybridization
to a given oligonuclotide (E(b) + E(p) << E(h)), then the inde-
pendent measurements of probe-pair differences more
closely approximate independent measurements of differ-
ences in gene expression. In the most extreme case - if E(h) is
sufficiently larger than E(b) + E(p) - each oligonucleotide in
the probe set could be considered as an independent meas-
urement of gene expression and the probability of observing
a given number of probe pairs changing under the null
hypothesis would be determined by the binomial
distribution.
To explore this possibility, we implemented an algorithm,
hereafter designated ChipStat, that takes corresponding
probe pairs across two comparison groups and tests them for
statistical significance with P less than a fixed value (hereafter
denoted pps). To avoid making assumptions about equal vari-
ance in both groups, a heteroscedastic t-test is used. We
would expect that probe sets in which larger numbers of indi-
vidual probe pairs show a significant change in the same
direction are more likely to be measuring differentially regu-
lated genes. Thus, for any given probe set, the number of
probe pairs (0-16) changing in a given direction with P less
than pps is tabulated and used as a measure of the significance
of change in gene expression. We simulated the expected
behavior of this algorithm under the null hypothesis (no dif-
ference in gene expression) across various ratios of E(b) +
E(p) and E(h) (see Materials and methods for details). Results
are shown in Figure 1.
Validation and optimization of the ChipStat algorithm
Although this approach provides a statistical methodology for
identifying changes in gene expression, it is only possible to
directly calculate a P value associated with this change in lim-
iting cases. If E(h) >> E(b) + E(p), the binomial distribution
can be used to calculate the resulting significance (given the
number of changes, total number of probe pairs, and pps);
however, the relative contributions of E(h), E(b), and E(p) to
the total error function are not known a priori.
To empirically measure the null distribution for three-sample
versus three-sample comparisons, a cohort of independent
control samples for our experimental system was generated.
To do this, the third, fourth and fifth mammary glands were
harvested from 18 age-matched 5-week-old control female
mice. After extraction of RNA, groups of three animals were
ChipStat behavior using simulated biological/experimental + hybridization noise model Figure 1
ChipStat behavior using simulated biological/experimental + hybridization noise model. The behavior of the ChipStat algorithm was evaluated (pps = 0.05, 
16 probe pairs per probe set) using a Monte Carlo model in which the ratio of biological + experimental noise (E(b) + E(p)) to hybridization noise (E(h)) is 
constant (see text for further details). Results are shown for E(h) = 0 (Exp noise only; blue), E(h) = E(b) + E(p) (Hyb noise = Exp noise; red), E(h) = 2 × 
(E(b) + E(p)) (Hyb noise = 2 × Exp noise; green), and E(b) + E(p) = 0 (Hyb noise only; yellow). The total number of probe sets simulated (11,820) was 
chosen to match the number of probe sets containing 16 probe pairs per probe set on the Affymetrix MG_U74Av2 array. The number of probe pairs 
increasing by chance is shown on the x axis, and the fraction of total probe sets simulated is shown on the y axis. This simulation was repeated 100×, and 
the average of these results is shown. (a) Probability of the indicated number of probe pairs increasing. (b) Cumulative P value (equal to or greater than 
the indicated number of probe pairs changing).
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pooled to create six initial RNA samples. Biotinylated cRNA
was then independently prepared from these pooled RNA
samples and hybridized to Affymetrix MG_U74Av2 oligonu-
cleotide microarrays, yielding six datasets. All possible three
by three combinations were compared across 11,820 probe
sets (corresponding to all probe sets on the MG_U74Av2 that
contain exactly 16 probe pairs), and the cumulative distribu-
tion of false positives as a function of pps and the number of
probe pairs changed was tabulated. Results are shown for pps
= 0.05 (Figure 2). It is notable that very few false positives are
associated with large numbers (more than 10/16) of probe
pairs changing. While the number of false-positive probe sets
does not decline as rapidly as the binomial distribution, the
overall curve is consistent with a large component of hybridi-
zation noise (compare Figures 1 and 2), suggesting the utility
of a probe-level approach. Likelihood maximization of our
initial statistical model (E ~ N, ignoring probe-specific
effects) using results for low numbers of probe pairs (0 to 6)
changing suggests that E(h) (hybridization noise) is approxi-
mately 2.5 times greater than E(b) + E(p) (experimental
noise). We note, however, that the empirically derived null
distribution can be used to derive a valid test of significance
for ChipStat regardless of the validity of the underlying model
and without any direct calculation of relative noise contribu-
tions by E(h), E(b) and E(p).
An ideal method for identifying differentially regulated genes
would maximize the number of genes identified while main-
taining a low fixed number of expected false positives. We
have previously shown the utility of testing the statistical
overlap of discrete gene lists with biologically relevant anno-
tation in order to identify functional pathways during murine
mammary gland development [4]. This maximization is
therefore of particular experimental interest. To evaluate the
ChipStat algorithm from this perspective, we performed trip-
licate microarray measurements of RNA derived from the
mammary glands of independent pools (more than 10 ani-
mals per pool) of wild-type female FVB mice harvested at 2 or
5 weeks of postnatal development. We wished to determine
the number of statistically significant increases in gene
expression from 2 to 5 weeks of age, a period of postnatal
development that encompasses the rapid epithelial prolifera-
tion that accompanies ductal morphogenesis in the mam-
mary gland at the onset of puberty [17].
ChipStat was used to analyze differences between the 2- and
5-week mammary gland samples (pps  = 0.05), and the
number of statistically significant increases was measured as
a function of the number of genes expected to appear on the
list by chance. Results are shown in Figure 3a. The number of
expected false positives was empirically obtained from the
negative-control dataset described previously. Thus, for
example, under conditions pps = 0.05 with 8/16 probe pairs
increasing, where around five genes are expected to be iden-
tified by chance, we find that the measured number of differ-
entially regulated genes is around 160. This corresponds to a
false-positive rate of approximately 3% (or, conversely, a
true-positive rate of approximately 97%). It is also apparent
(Figure 3a) that the sensitivity of detection can be 'tuned' on
the basis of the number of false positives that are deemed
acceptable.
To determine whether the sensitivity of this algorithm could
be further optimized, similar analyses were performed at var-
ious values of pps (Figure 3b). These data suggest that relative
sensitivity as a function of false-positive rate is maximized at
pps approximately equal to 0.04-0.05 (note the similarity of
these curves in Figure 3b). Furthermore, while certain other
values of pps yield increased sensitivity at specific points (for
example, pps = 0.03 at around four genes expected by chance;
data not shown), values of 0.04-0.05 appear appropriate
across most highly-significant P values. A marked decrease in
sensitivity for a given false-positive rate is noted both at low
(0.01) and high (0.1, 0.15) values of pps.
Although the use of negative-control samples provides a
definitive method for evaluating the behavior of our statistical
algorithms, we independently verified these results using
northern blot hybridization. Genes differentially expressed
(6/16 probe pairs increasing, pps = 0.04) from 2 to 5 weeks of
mammary gland development were identified, and analysis of
the control data suggested that fewer than 10 increases would
Empirical measurement of the ChipStat null distribution Figure 2
Empirical measurement of the ChipStat null distribution. Mammary gland 
tissue was harvested from six separate, biologically identical pools of FVB 
(MTB) mice, and hybridization data to Affymetrix MG_U74Av2 
microarrays was obtained. Comparisons of all possible three versus three 
combinations (total 20) were performed using ChipStat (pps = 0.05), and 
the number of significant increases was tabulated for all probe sets 
containing 16 probe pairs per probe set (total = 11,820). The cumulative 
average probability is shown as a function of the number of probe pairs 
that increase within the probe set.
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be expected by chance at this significance level (correspond-
ing to P < 7.7 × 10-4). Manual inspection of the resulting list
revealed the presence of a number of genes known to be
upregulated during this developmental transition, including
cytokeratin 19 (Krt1-19), cytokeratin 8 (Krt2-8), and κ casein
(Csnk) .  H o w e v e r ,  t o  a v o i d  b i a s  t o w a r d  p r e v i o u s l y  s t u d i e d
genes or known genes with high fold change, genes were ran-
domly selected from subsets of this list corresponding to
high-stringency (P < 2.2 × 10-4), low-stringency with high fold
change (2.2 × 10-4 <P < 7.7 × 10-4, ≥ 1.8-fold change), and low-
stringency with low fold change (2.2 × 10-4 <P < 7.7 × 10-4, <
1.8-fold change). Results from northern blot analyses using
probes for these randomly selected genes are shown in Table
1. Of nine genes selected, eight were shown to change signifi-
cantly via northern blot analysis.
Of note, the single gene that did not show a significant change
(Ldh1) was from the low-stringency group and was predicted
to show only a 1.37-fold change. In contrast, northern hybrid-
ization confirmed the differential expression of other genes
with only modest fold-changes (for example, Sqstm1, 1.48-
fold change from 2 to 5 weeks). As the genes tested were not
biased toward higher fold change (only 2/75 genes with fold
change > 3 were randomly selected for northern confirma-
tion), our data demonstrate the ability of ChipStat to reliably
detect the types of small, reproducible changes in gene
expression that are necessary for whole-organ analysis.
Comparison of ChipStat with other analytical methods
Other methods of detecting differential gene expression have
been widely utilized, including SAM [11] and dChip [8]. As
Relative detection sensitivity of differential gene expression Figure 3
Relative detection sensitivity of differential gene expression. The number of probe sets shown to increase from 2 to 5 weeks of murine mammary gland 
development was tabulated as a function of the number of probe sets expected to increase by chance. (a) ChipStat (pps = 0.05), vs t-test. (b) Optimization 
of ChipStat sensitivity as a function of pps. (c) ChipStat vs other techniques: reported P values. For ChipStat, the number of probe sets expected to 
increase by chance was empirically estimated from negative control data. For the t-test, SAM, dChip and logit-T, reported P values from the 2-week vs 5-
week mammary gland comparison were used. (d) ChipStat vs other techniques: empirical P values. The number of probe sets expected to increase by 
chance was empirically estimated for ChipStat, t-test, SAM, dChip and logit-T (representative points).
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previously discussed, SAM utilizes an aggregate (probe-set-
level) estimate of gene expression as its analytical starting
point. Similarly, although dChip utilizes probe-cell-level
analysis to determine the level and statistical bounds of gene
expression, it does not explicitly make use of probe-level com-
parisons for identifying differentially regulated genes. More
recently, the logit-T algorithm, which in contrast to SAM and
dChip utilizes probe-pair-level comparisons for statistical
testing, has been shown to improve differential expression
testing performance in a variety of Latin square datasets
reflecting technical replicates of samples with spiked-in tran-
scripts [10]. We therefore wished to determine the perform-
a n c e  o f  t h e  C h i p S t a t  a l g o r i t h m  r e l a t i v e  t o  t h e s e
methodologies. Further, as our control dataset incorporates
biological and experimental variability in addition to sample
preparation and hybridization noise, we reasoned that it
would provide a more appropriate estimate of the perform-
ance of these algorithms when analyzing data from an exper-
imentally plausible animal model.
SAM, dChip, the t-test and logit-T all provide a P value esti-
mating statistical significance in the absence of an empirical
measurement of the underlying null distribution; Figure 3c
shows a comparison with ChipStat when using these esti-
mated P values. However, as ChipStat requires the additional
information provided by this empirical distribution for statis-
tical calibration, the inherent performance of other algo-
rithms may be underestimated if they are not similarly
calibrated. To correct for this difference, the significance of
SAM, dChip and logit-T values were assessed using all three
by three combinations of the null dataset (given the permuta-
tion-based calibration of false-discovery rate utilized by SAM,
note that SAM values are not predicted to improve signifi-
cantly using this method of calibration). Results are shown in
Figure 3d. In the case of the t-test, results obtained using
calculated P values are generally within 5% of comparable
results using empirically calibrated P  values. Logit-T and
dChip appear much less sensitive when using reported P val-
ues, although both of these techniques show improvement
when calibrated using the control dataset. Of particular note,
logit-T performs only slightly less well than ChipStat when
calibrated against our control distribution, consistent with
the fact that it was the only other algorithm considered that
performs probe-pair-level comparisons when testing for dif-
ferential gene expression.
Design and validation of the Intersector algorithm
Although the Affymetrix Microarray Suite (MAS) software
utilizes probe-level information in identifying differentially
expressed genes, its use has been restricted to single-array
comparisons. As a result, it has been widely recognized that
this approach generates an unacceptably high number of
false-positive results. The use of replicate samples, however,
might be expected to lower the false-positive rate while
achieving a higher sensitivity. We therefore combined pair-
wise comparisons between triplicate data points in two differ-
ent groups (that is, nine comparisons in total) and
determined differential expression based on the Affymetrix
call (for example, increases + marginal increases) for these
comparisons. A similar technique, in which a simple majority
cutoff (5/9 changes) was considered to denote significant
change, has recently been described [18]. Although this
approach involves N2  comparisons in general for equal
groups of N arrays, it is easily feasible for three-sample versus
three-sample comparisons. We have designated this
approach Intersector. Significantly, the control data previ-
ously generated to calibrate ChipStat also allow us to deter-
Table 1
Northern blot validation of differential gene expression
Probe set ID Accession number Gene Fold change Probe pairs increasing Differential expression 
confirmed
99067_at X59846 Gas6 3.41 16/16 x
100064_f_at M63801 Gja1 1.67 12/16 x
102016_at M61737 Fsp27 2.07 11/16 x
93996_at X01026 Cyp2e1 11.6 10/16 x
97507_at X67809 Ppicap 2.85 9/16 x
101995_at U40930 Sqstm1 1.48 8/16 x
93096_at AA986050 3010002H13Rik 2.65 7/16 x
102791_at U22033 Psmb8 1.65 7/16 x
96072_at M17516 Ldh1 1.37 6/16
Genes identified as being differentially expressed were randomly chosen for verification by northern blot hybridization (see text for description). 
Gene identifiers are shown along with fold changes, numbers of probe pairs increasing (as identified by ChipStat with pps = 0.04), and confirmation of 
differential expression.http://genomebiology.com/2005/6/2/R20 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. R20.7
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mine the empirical false-positive rate for Intersector as a
function of the number of 'increase' calls and to perform
direct comparisons with other algorithms.
The performance of the Intersector algorithm in comparing
2- versus 5-week mammary gland gene expression is shown
in Figure 4a. Interestingly, the Intersector algorithm is able to
achieve a slightly improved sensitivity at a given false-positive
rate when compared with ChipStat. To determine whether the
particular version of the MAS algorithm influences this result,
all analyses were run using difference calls from both MAS
4.0 and MAS 5.0 (see Figure 4a). Although the number of
changes required to achieve similar sensitivity was different,
the Intersector results from MAS 4.0 and MAS 5.0 are com-
parable at a given false-positive rate.
Given substantial differences between the types of probe-pair
comparisons performed by ChipStat and MAS, we next
wished to ascertain if these algorithms identify the same sets
of  u pr eg u la te d ge n es.  D ir ect  compa ri son  re qu ir es t h at t h e
Intersector and ChipStat performance Figure 4
Intersector and ChipStat performance. (a) The number of probe sets shown to increase from 2 to 5 weeks of murine mammary gland development was 
tabulated as a function of the number of probe sets expected to increase by chance, and a comparison of ChipStat (pps = 0.05), Intersector (MAS 5.0 
change calls), and Intersector (MAS 4.0 change calls) is shown. (b) Venn diagram showing distinct probe sets identified by ChipStat and Intersector. The 
number of genes shown to be differentially expressed at the indicated expected false-positive levels is shown for ChipStat (CS) (pps = 0.04), Intersector (IT) 
with MAS 5.0 calls, and Intersector (IT) with MAS 4.0 calls. (c) False-positive rates for ChipStat (CS 6/16: pps = 0.05, 6/16 probe pairs increasing; CS 9/16: 
pps = 0.05, 9/16 probe pairs increasing), Intersector (MAS5) (IT 7/9: 7/9 increases or marginal increases; IT 8/9: 8/9 increases or marginal increases), or 
ChipStat and Intersector together (Combined: intersection of CS 6/16 and IT 7/9) are shown. (d) Combined performance of ChipStat and Intersector. 
Increases from 2 to 5 weeks of mammary gland development are shown for ChipStat alone (pps = 0.05), Intersector alone (MAS 5.0), and optimized 
intersections of ChipStat and Intersector (see Additional data file 1).
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analyses result in comparable false-detection rates. We there-
fore compared the lists at thresholds corresponding to
approximately 2.5 genes expected by chance, and the closest
available threshold with each algorithm was chosen. The
resulting thresholds were Intersector (MAS4) 7/9 (1.75
expected by chance), Intersector (MAS5) 8/9 (2.8 expected by
chance), and ChipStat (.04) 8/16 (2.68 expected by chance).
Notably, examination of these lists demonstrates that each
algorithm (Intersector with MAS 4.0 data, Intersector with
MAS 5.0 data and ChipStat) detects a discrete set of genes
that are not detected by the others (Figure 4b). This is partic-
ularly intriguing since empirically estimated false positive
rates suggest that these groups of genes are not likely to
reflect chance fluctuations alone. Thus, in addition to identi-
fying a core set of regulated genes, the Intersector and Chip-
Stat algorithms each detect sets of complementary,
nonoverlapping genes that change significantly.
To confirm this result, five out of the 13 genes uniquely iden-
tified by ChipStat were randomly chosen for confirmation.
One of these genes was undetectable by northern blot hybrid-
ization, and the remaining 4/4 showed differential expression
in the predicted direction (5 weeks > 2 weeks) (Table 1, and
data not shown). This demonstrates that, at comparable lev-
els of statistical stringency, ChipStat correctly identifies dif-
ferentially expressed genes that are not identified by
Intersector. Further, having directly tested approximately
40% of all genes in this category, no false positives were iden-
tified. Examination of lower stringency lists (9.5 expected by
chance from ChipStat, 7.4 expected by chance from Intersec-
tor using MAS5) also revealed sets of genes identified by
ChipStat or Intersector alone. For example, the 'Intersector
only' list created at this lower stringency contains α-, β-, and
γ-casein; previous work in our lab has demonstrated that
these genes are differentially regulated with expression at 5
weeks greater than that at 2 weeks (data not shown).
Development of a hybrid approach
Given the presence of genes uniquely identified by Intersector
or ChipStat at a given false positive rate and the feasibility of
performing Intersector analysis on small numbers of repli-
cates, we next explored whether a combination of these
approaches could further improve overall detection. To test
this, all possible pairwise threshold combinations of ChipStat
(pps = 0.05, 0/16 to 16/16 probe pairs changing) and Intersec-
tor (0/9 to 9/9 increases or marginal increases) were com-
bined, and aggregate lists of genes identified by both
algorithms were tabulated (see Additional data file 1). The
results demonstrate that a combination of these two
approaches can lower the expected false positive rate while
maintaining a high sensitivity. For example, the combination
of ChipStat (pps = 0.05, 6/16 probe pairs increasing) and
Intersector (7/9 increases + marginal increases) detects 209
increasing probe sets with only 3.4 expected to increase by
chance (expected false-positive rate less than 2%). A compar-
ison of the false-positive rates for single (ChipStat or Intersec-
tor alone) and combined (ChipStat and Intersector)
approaches is shown in Figure 4c. Note that the total number
of probe sets detected by the combined approach shown in
Figure 4c is greater than the number detected by the single
approach with a comparable false-detection rate (209 probe
sets and 173 probe sets, respectively). The behavior of optimal
combinations with respect to the number of genes detected is
shown in Figure 4d.
One additional feature of this combined approach is the abil-
ity to 'fine-tune' the number of expected false positives. That
is, while Intersector (MAS5) allows no choice between
approximately three and approximately seven expected false
positives (2.8 and 7.35, corresponding to 8/9 or 7/9 changes,
respectively), the combined approach provides a smoother
continuum of values. More important, these data show that,
for certain targeted numbers of expected false positives, a
combination of ChipStat and Intersector can provide
improved performance in gene detection compared with
either algorithm alone.
Genomic characterization of early mammary gland 
development
The goal of these methodological developments has been the
elucidation of biological mechanisms underlying mammary
gland development and carcinogenesis. We therefore used
the hybrid ChipStat/Intersector lists representing early mam-
mary gland development as a basis for further exploration of
developmental processes during this time period. A complete
list of genes differentially expressed between 2- and 5-week
murine mammary gland was compiled using the techniques
described above. The results are listed in Additional data file
2.
To identify coherent functional patterns of gene expression
during neonatal development through the onset of puberty,
statistically significant associations between Gene Ontology
(GO) categories [19] and lists of up- and downregulated genes
were identified using EASE [20]. Multiple testing correction
was performed using within-system bootstrapping, and a cor-
rected significance threshold of P less than 0.05 was used.
Results are shown in Table 2. Upregulated genes were associ-
ated with a total of 22 GO categories, and downregulated
genes with 10 categories. In addition, this approach provides
a convenient test of whether the increased sensitivity of Chip-
Stat/Intersector yields corresponding power in identifying
patterns of biological activity. To test this directly, lists of dif-
ferentially expressed genes with the same number of expected
false positives (empirically calibrated as previously) were
identified using dChip and logit-T. These lists were then
tested for association with GO annotation, and the results are
shown (Table 1, Figure 5). Of note, ChipStat/Intersector lists
were associated with a greater number of GO categories than
were dChip or logit-T, and this was true for both up- and
downregulated gene lists. Consistent with our suggestion that
logit-T should be most similar to ChipStat/Intersectorhttp://genomebiology.com/2005/6/2/R20 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. R20.9
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because of its use of probe-pair-level comparisons, logit-T
also generated lists that are statistically associated with a
larger number of GO categories than did dChip (Figure 5),
although it did not outperform ChipStat/Intersector.
ChipStat/Intersector identified 22/22 of categories associ-
ated with any of the list of upregulated genes and 10/11 cate-
gories identified using any of the lists of downregulated
genes. A single downregulated category ('cellular component:
extracellular') was associated only with the logit-T list.
Table 2
Association with GO annotation
System Gene category CS LT DC
(a) Upregulated genes
GO Biological Process Defense response x x x
GO Cellular Component Extracellular space x x
GO Cellular Component Extracellular x x
GO Biological Process Response to biotic stimulus x x x
GO Biological Process Immune response x x x
GO Biological Process Response to external stimulus x x x
GO Biological Process Organismal physiological process x x x
GO Biological Process Antigen presentation x x
GO Biological Process Response to stimulus x x x
GO Biological Process Antigen presentation\, endogenous antigen x
GO Molecular Function MHC class I receptor activity x
GO Biological Process Antigen processing x x
GO Biological Process Complement activation x x
GO Biological Process Antigen processing, endogenous antigen via MHC class I x
GO Biological Process Response to pest/pathogen/parasite x x x
GO Biological Process Humoral defense mechanism (sensu Vertebrata) x
GO Molecular Function Pheromone binding x x
GO Molecular Function Oxidoreductase activity x
GO Molecular Function Oxidoreductase activity, acting on the aldehyde or oxo 
group of donors
x
GO Molecular Function Odorant binding x x
GO Molecular Function Transmembrane receptor activity x
GO Biological Process Humoral immune response x
(b) Downregulated genes
GO Cellular Component Mitochondrion x x
GO Biological Process Main pathways of carbohydrate metabolism x x
GO Biological Process Tricarboxylic acid cycle x x
GO Biological Process Energy derivation by oxidation of organic compounds x x
GO Biological Process Energy pathways x x
GO Cellular Component Mitochondrial membrane x
GO Biological Process Carbohydrate metabolism x x
GO Cellular Component Inner membrane x
GO Biological Process Blood vessel development x
GO Cellular Component Mitochondrial inner membrane x
GO Cellular Component Extracellular x
Lists of differentially expressed genes derived from a hybrid ChipStat/Intersector approach (ChipStat: pps = 0.05, 6/16 probe pairs increasing AND 
Intersector: 7/9 increases + marginal increases), logit-T, and dChip were associated with GO terms using EASE [20]. Individual terms are annotated 
according to whether association with the given annotation group was statistically significant (P < 0.05 using within-system bootstrap to account for 
multiple testing) using lists derived from ChipStat/Intersector (CS), logit-T (LT), or dChip (DC). (a) Association with lists of upregulated genes. (b) 
Association with lists of downregulated genes.R20.10 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. http://genomebiology.com/2005/6/2/R20
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To provide a crude check on the reliability of these results in
addition to the confirmation previously performed, gene lists
were examined for association with previously described bio-
logical processes. In addition to individual genes that are con-
sistent with epithelial proliferation and differentiation
(discussed above), several statistically associated categories
represent pathways that have been previously described in
the mammary gland during this developmental window [4].
These include 'blood vessel development' and 'mitochondrial
inner membrane'. The latter category reflects the previously
reported decrease in brown adipose tissue at the end of the
neonatal period and the corresponding decrease in the capa-
bility of the mouse to utilize adaptive thermogenesis to main-
tain body temperature. Brown adipose tissue is not only rich
in mitochondria, but the fatty-acid metabolic pathways nec-
essary for adequate thermogenic activity are also spatially
localized at the inner mitochondrial membrane. Of note, this
category only reached statistical significance using the Chip-
Stat/Intersector list.
Interestingly, 'pheromone binding' and 'odorant binding' cat-
egories are also associated with upregulated expression at the
onset of puberty. Genes within these categories are primarily
members of the major urinary protein (MUP) gene family,
and MUP transcripts (Mup1, Mup3, Mup4, Mup5) account
for four of the five most highly upregulated genes from 2 to 5
weeks. Large quantities of MUPs are synthesized in the male
liver and excreted in the urine, where they bind pheromone
and play a role in signaling for complex behavioral traits
[21,22]. MUP levels are upregulated during puberty in the
liver, although expression levels are much higher in males
than in females. While MUP expression within the mammary
gland has previously been reported [23,24], its expression
was considered to be detectable only with the onset of preg-
nancy. Our data show that MUPs are highly upregulated in
the female mammary gland during the 2- to 5-week transi-
tion. Interestingly, Slp  (sex-limited protein), which also
shows sex-restricted expression in the male liver and - like
Mup expression - is normally repressed by Rsl [25], is also
significantly upregulated during this period.
Additional examination of these gene lists revealed an inter-
esting transcriptional pattern that is not reflected in the cur-
rent GO hierarchy. The nontranslated RNA transcript Meg3/
Gtl2  is significantly downregulated from 2 to 5 weeks of
development, and its reciprocally imprinted neighbor Dlk1
[26] shows a similar decrease. This is noteworthy because two
other genes with decreasing expression, H19 (nontranslated
RNA) and Igf2, are also reciprocally imprinted neighbors,
suggesting the possibility of a common regulatory mechanism
for altering expression from loci exhibiting this genomic
organizational structure (see [27]).
Discussion
The ability to reliably detect changes in gene expression is
critical for the analysis of experimental microarray data. This
problem assumes particular importance when analyzing
complex mixtures of cells, such as those derived from a whole
organ during ontogeny. The challenge can be most clearly
seen by considering a small subpopulation of cells that dem-
onstrate a marked change in gene expression. If the expres-
sion of this gene is uniform and low throughout the rest of the
tissue, the biologically relevant change within a few cells will
appear as a low fold change in organ-wide gene expression. A
variety of such nonabundant yet developmentally critical cell
types have been described. For example, the proliferative
capacity of small structures in the mammary gland known as
terminal end buds gives rise to the extensive ductal structure
that is elaborated during puberty [17]. More recently, the
characteristics of mammary stem cells have been described,
and these cells have been suggested to serve as targets for car-
cinogenesis [28,29]. To facilitate the study of such subpopu-
lations within a whole-organ context, therefore, we have
developed a novel approach to the analysis of Affymetrix oli-
gonucleotide microarray data.
A variety of nonparametric and parametric statistical tests,
including variants of Student's t-test, have been used to iden-
tify significant changes in gene expression using replicate
microarray data. Given the substantial economic investment
required for large microarray experiments, attempts have
also been made to improve detection of differentially
regulated genes through better estimates of the null distribu-
tion using permutation analysis; the use of software incorpo-
Quantitative association with GO categories Figure 5
Quantitative association with GO categories. The number of GO terms 
found to be statistically associated (P < 0.05 using within-system bootstrap 
to account for multiple testing) with lists of differentially regulated genes 
(2 vs 5 weeks of murine mammary gland development) is shown. Lists of 
up- and downregulated genes were generated using dChip (DC), logit-T 
(LT) and a ChipStat/Intersector hybrid (CS/IT) that were matched in 
stringency to give equivalent numbers of expected false-positive genes.
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rating such methods, such as SAM [11], has become
widespread. A different approach to improved detection
(dChip, see [8]) has attempted to use probe-level information
to derive an improved estimate of relative gene expression
before assessing differential regulation.
While much work has focused on such use of probe-level anal-
ysis for estimating gene expression [8,9], the analysis of rep-
licate data at the probe level for identifying differentially
expressed genes has only recently become a focus [10,30]. In
particular, if hybridization noise contributes a substantial
portion of the overall noise inherent in microarray measure-
ments, the use of multiple probe pairs devoted to measuring
a single gene suggests a potential approach to overcoming
this noise.
The ChipStat algorithm uses heteroscedastic t-test compari-
sons between probe pairs, and the number of probe pairs that
change greater than a significance threshold are tabulated. A
greater number of consistently changing probe pairs should
indicate that the difference is less likely to be due to
hybridization noise, and thus this number relates the overall
probability that the probe set is measuring a true change in
gene expression. The processing time for the ChipStat algo-
rithm scales as a linear function of the number of replicates
processed (O(N)), and thus it is feasible to apply this
approach to much larger numbers of samples.
To assess the statistical significance of ChipStat results, it was
necessary to empirically measure the underlying null distri-
bution. While the recent availability of a number of publicly
available Latin square datasets representing measurements
of spiked-in control samples has greatly facilitated measure-
ments of this sort [31], these datasets reflect technical repli-
cates without biological noise. As we have demonstrated, the
b e h a v i o r  o f  t h e  C h i p S t a t  a l g o r i t h m  w o u l d  b e  e x p e c t e d  t o
change depending on the relative contributions of biological/
experimental noise and probe-level hybridization noise.
Thus, a set of negative control samples reflecting an experi-
mental system that include biological noise was required.
To generate these samples, mammary glands from six inde-
pendent cohorts of mice were harvested. These data provide a
true, gold-standard negative control within a representative
mammalian experimental system, and we anticipate that
their public availability will be similarly useful to the broader
scientific community in analytical development and valida-
tion. Furthermore, the use of this dataset as an empirical
calibration control for ChipStat argues that these results will
be valid independent of the adequacy of the statistical noise
model used. It is worth noting that the use of pooled groups
of animals is likely an important parameter, as single-animals
groups, for example, would be expected to exhibit increased
biological variability and thus decrease the proportional con-
tribution of hybridization noise.
Given empirical measurements of the expected number of
false positives for a given set of analytical parameters, it was
possible to assess the relative sensitivity of a variety of algo-
rithms using a positive control dataset (2-week versus 5-week
murine mammary gland) known to contain a substantial
number of increasing transcripts. Consistent with our
hypothesis that probe-level comparison analysis should
improve sensitivity, ChipStat was able to substantially out-
perform a variety of methods (t-test, SAM, and dChip) based
on aggregate gene-expression measures (Figures 3c,d). Fur-
thermore, this remained the case even when the statistical
significance of dChip was recalibrated using a negative con-
trol dataset.
Recently, Lemon et al. have described a method (logit-T) that
is also based on probe-level t-test comparisons for identifying
differentially expressed genes [10]. The logit-T algorithm
estimates statistical significance using the median result of t-
tests performed on log-transformed PM probe data. ChipStat
differs from this approach in several significant respects.
These include the use of a fixed P value threshold for pairwise
probe comparisons and the use of the degree of reproducibil-
ity across the entire probe set as an indication of statistical
significance. Results from the empirical control data suggest
that ChipStat performs slightly better than logit-T in most
cases within our biological system. Interestingly, however,
the advantage of ChipStat over logit-T was more modest than
the advantage over SAM, dChip, and the t-test; as logit-T also
uses probe-level comparisons, this result is consistent with
our overall observations regarding the increased power of
probe-based analysis. It is also worth noting that the nominal
P values derived from both logit-T and dChip substantially
underestimated statistical significance prior to correction
with our control data, suggesting that, for example, the
median P value cannot be used to directly assess significance
without such correction.
One additional difference between ChipStat and logit-T stems
from the use of mismatch (MM) probe cells (ChipStat) and
log-transformed data (logit-T). As currently implemented,
the ChipStat algorithm compares differences in probe pair
(PM - MM) values rather than in PM values alone. Interest-
ingly, the use of PM values within the ChipStat algorithm does
not result in superior performance (data not shown), and
log(PM) data yield performance that is roughly comparable to
PM - MM (data not shown). Further work will be required to
determine if the log(PM) approach can be adapted to improve
the performance of ChipStat.
The Intersector algorithm tabulates MAS calls from all pair-
wise comparisons across replicate groups. As we have shown,
this algorithm provides the most sensitive method for detect-
ing gene expression changes at low false-detection rates.
However, it suffers from several substantial drawbacks. First,
the proprietary nature of the Affymetrix algorithm and its
associated decision matrices limits the ability to automate theR20.12 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. http://genomebiology.com/2005/6/2/R20
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analytical process. Additionally, because N2 pairwise compar-
isons are required for equal groups of N replicates (that is,
O(N2)), this method is not easily scalable to larger numbers of
samples. In contrast, ChipStat scales linearly with N, and the
use of the heteroscedastic t-test also makes it possible to
precompute results for a (potentially large) baseline control
population against which multiple comparisons will be per-
formed. While both approaches are feasible for triplicate
comparisons, extension of Intersector to much larger num-
bers is unlikely to be practical.
A third disadvantage to the Intersector approach stems from
the lack of a detailed model for its underlying statistical
framework. Both ChipStat and Intersector, as currently
described, require the use of control samples to generate an
estimate of statistical significance. Thus, extension of these
results to encompass either a substantially different experi-
mental system or larger numbers of replicates will require the
generation of new empirical significance curves. In the case of
large numbers of replicates, however, the cost of generating
such data is likely to remain prohibitive at least in the near
future. Statistical simulations of ChipStat behavior may, how-
ever, provide a mechanism for extending the current control
curves for larger datasets. This approach would rely on the
relative estimates of E(b) + E(p) and E(h) obtained by fitting
the current empirical curve derived from six samples. While a
small number of probe sets change more often than would be
predicted by simulation, it should be possible to conserva-
tively estimate an upper bound to the P value curve by over-
estimating the relative contribution of E(b) + E(p) vs. E(h).
Further experimental work will be required to confirm this
possibility.
One caveat to this approach is that the simplified statistical
model that we have used to illustrate the theoretical advan-
tages of probe-level comparisons does not account for the
variability in the behavior of specific probe cells that exist on
Affymetrix arrays. In contrast, the model-based approach to
signal estimation implemented in dChip explicitly incorpo-
rates such variability and has been shown to provide a good fit
to empirical measurements of array data [8,32]. It is likely
that incorporation of probe-specific parameters in this way
would improve the ability to predict the theoretical behavior
of ChipStat and provide a better estimate of hybridization
noise from our empirical data. Given this likelihood, current
estimates of the relative contributions of E(b) + E(p) and E(h)
should be taken as provisional.
In this context, it is worth noting that the ability to perform
our current validation and to tune both Intersector and Chip-
Stat was critically dependent on the gene-expression datasets
derived from our independent cohorts of control animals.
One might naively assume, in the absence of true negative
control data, that robust changes in gene expression should
be detected by simply taking the Affymetrix MAS calls and
requiring that they consistently demonstrate increases for all
pairwise comparisons. In contrast, our data show that the
Intersector algorithm can achieve increased sensitivity while
retaining an appropriately low (and defined) false-positive
rate. Both the Intersector and ChipStat algorithms can be
tuned using negative control data for sensitivity versus false-
positive rate, depending on the type of analysis and applica-
tion-specific tolerance for false-positive calls. Furthermore,
these algorithms can be combined to further improve their
sensitivity. As we have demonstrated that each of these algo-
rithms detects a population of probe sets not identified by the
other at a comparable stringency, this combined approach
may yield the best result. Given these considerations, we
favor the use of the hybrid ChipStat/Intersector approach for
small number of replicates (around three), with ChipStat
alone being useful for large numbers of replicates. Although
ChipStat shows greater sensitivity than logit-T at moderate
numbers of false positives (more than five expected false pos-
itives out of 12,488 probe sets), their comparable perform-
ance at high stringency (less than five expected false
positives) suggests that the overlap in genes identified by
these two techniques may also be of interest.
An additional piece of evidence for the utility of our approach
is provided by the statistical association of GO annotation
with lists derived from ChipStat/Intersector, dChip or logit-T.
At the level of significance tested (3.4 genes per list expected
by chance), ChipStat/Intersector lists were statistically asso-
ciated with a greater number of GO terms than were lists
derived from dChip or logit-T. Furthermore, as would be pre-
dicted from the fact that logit-T is also a probe pair-level com-
parison method, logit-T lists are associated with GO terms at
a level that is intermediate between dChip and ChipStat/
Intersector. One of the terms associated only with the Chip-
Stat/Intersector list of downregulated genes is 'mitochondrial
inner membrane'; this example is particularly noteworthy in
light of previous work demonstrating a presumptive role for
enzymes of fatty acid oxidation in adaptive thermogenesis
during the neonatal period [4].
It should be noted that these results depend on the level of
significance chosen for generation of the original lists, and an
increase in the total number of differentially expressed genes
identified may actually decrease the statistical significance of
a given association if it does not result in the detection of
more genes within the category in question. Despite some
caveats as to the generalizability of these results, our data
demonstrate that the improved sensitivity of ChipStat/Inter-
sector can measurably influence the ability to interpret pat-
terns of biological activity.
Early murine mammary gland development
For the FVB murine mammary gland, the period from 2 to 5
weeks of age encompasses critical developmental milestones
that include the suckling-weaning transition as well as the
profound hormonal changes that characterize the onset of
puberty and its consequent rapid ductal epithelial prolifera-http://genomebiology.com/2005/6/2/R20 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. R20.13
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tion. Our present work has more completely characterized
changes in the transcriptome that occur during early murine
mammary gland development than have previous reports. A
total of 213 upregulated and 130 downregulated probe sets
were identified under conditions designed to yield a low
expected false-positive rate (3.4 probe sets expected to
change by chance per list).
Four out of five of the most highly upregulated transcripts
through the onset of puberty are members of the MUP family
of odorant-binding proteins. MUPs are lipocalins that can
bind hydrophobic molecules such as pheromones, and they
have previously been shown to play a role both in the delivery
of signals within the urine as well as in the reception of these
signals on the nasal epithelium ([33,34]; see [35] for review).
Isoform-specific MUP expression has also previously been
reported in a number of secretory glands, including the
murine mammary gland [23,24]. However, detectable
expression has previously been reported only beginning with
the first pregnancy [23].
Our results demonstrate a striking increase in the expression
of a variety of MUP isoforms as the mammary gland makes
the transition from the neonatal period through the begin-
ning of puberty. This expression pattern is noteworthy given
the known effect of puberty on MUP expression in the liver
[36]. Interestingly, however, expression in the liver is mark-
edly greater in the male and has been causally linked to the
male pattern of growth-hormone pulses [36]. As this male-
specific pattern of expression has been shown to be Stat5b-
dependent, the availability of Stat5b -/- mice should allow
future determination of whether mammary expression is
mediated via a similar signaling pathway. Regardless of this,
despite an interval of over two decades since the first descrip-
tion of MUP expression in the mammary gland, a functional
role has still not been elucidated. Although it has long been
assumed that MUP synthesis occurs in the secretory epithe-
lium of expressing organs, our observation that these mole-
cules are upregulated during puberty (with a corresponding
approximately threefold downregulation following puberty,
data not shown) suggests that their functional role may not be
limited to the secretory function of the gland.
Delta-like kinase (Dlk1) is a member of the epidermal growth
factor (EGF) superfamily [37] that is encoded on murine
chromosome 12 [38]. Dlk1 is one of several genes showing
substantial (greater than fivefold) downregulation from 2 to 5
weeks of murine mammary gland development. As this gene
was first identified as a preadipocyte transcript that is down-
regulated during subsequent differentiation [38], we hypoth-
esize that its relatively high expression during the neonatal
period reflects ongoing differentiation of the mammary fat
pad. This kinase has also been shown to have a role in other
developmental contexts, specifically within neuroendocrine
tissues. Further work will be required to elucidate its specific
role in the mammary gland. Notable, however, is the corre-
sponding downregulation (more than 10-fold) of Meg3/Gtl2,
a noncoding RNA that is reciprocally imprinted with Dlk1
[26]. This Dlk1-Meg3/Gtl2  regulation has been compared
with Igf2-H19, another tandem pair of reciprocally imprinted
genes in which one member produces a noncoding RNA
[27,39]. Interestingly, both Igf2 and H19 are also downregu-
lated during this time period, suggesting the hypothesis that
a common regulatory mechanism exists for the tandem con-
trol of both imprinted genes at these loci. It will be particu-
larly important to determine whether there is functional
significance to this Igf2-H19 regulation, or whether it reflects
the epiphenomenal byproduct of a mechanism designed to
downregulate Dlk1 during adipocyte development.
Conclusions
We have developed two novel algorithms for the analysis of
Affymetrix oligonucleotide microarray data. We have vali-
dated these algorithms by using empirically derived distribu-
tions from control animals to calibrate their statistical
significance. These control data, which reflect both experi-
mental and biological sources of variability likely to be repre-
sentative of many mammalian experimental systems, should
facilitate further work in this area. For triplicate samples,
Intersector appears to provide the most sensitivity at a given
threshold of statistical significance, and its performance is
substantially superior to other widely used methods including
the t-test, SAM, dChip, and logit-T. However, its lack of scal-
ability, along with the baseline time required for processing,
make it unsuitable for larger numbers of replicates. ChipStat,
in contrast, provides comparable sensitivity with triplicate
samples and has the capability of handling much larger num-
bers of replicates in order to improve the reliable dectection
of small changes in gene expression. Both algorithms provide
a substantial increase in the ability to sensitively detect statis-
tically significant changes in gene expression within the con-
text of the whole mammary gland.
We have applied these techniques to the analysis of genomic
patterns during early murine mammary gland development.
In addition to detecting patterns reflecting known biology, we
have noted the coordinate upregulation of a class of molecules
n o t  p r e v i o u s l y  k n o w n  t o  b e  d i fferentially regulated in the
mammary gland. We also suggest that peri-pubertal changes
in the mammary gland may utilize mechanisms for tandem
upregulation of multiple imprinted regions. Our observations
suggest a variety of future directions for functional validation
and demonstrate the utility of coupling sensitive detection of
differential gene expression with pathway analysis for the elu-
cidation of biological patterns during organogenesis.R20.14 Genome Biology 2005,     Volume 6, Issue 2, Article R20       Master et al. http://genomebiology.com/2005/6/2/R20
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Materials and methods
Animals, RNA isolation, and northern blot 
hybridization
The third, fourth and fifth mammary glands were harvested
from FVB mice at the indicated time points. Samples from 2
and 5 weeks of age reflect triplicate pools of 10 animals at each
time point (total 60 animals). In addition, tissue from 18 con-
trol animals was harvested when they were 6 weeks and 4
days old. These control animals also carry a transgenic con-
struct consisting of the murine mammary tumor virus
(MMTV) promoter upstream of the reverse tetracycline trans-
activator (rtTA) and had been given 2.0 mg/ml doxycycline in
drinking water for 96 h before harvest. This line (previously
designated MTB) has been previously described, and no
developmental abnormalities have been noted [40]. All ani-
mal experimentation was conducted in accord with accepted
standards of humane care, and protocols for animal work
were approved by the University of Pennsylvania institutional
committee on animal care.
All tissue was snap frozen after removal of the lymph node
present in the fourth gland, and total RNA was isolated by
homogenization in guanidinium isothiocyanate and subse-
quent centrifugation through a cesium chloride cushion as
previously described [41]. Northern blot hybridization was
performed as previously described [42].
Arrays and hybridization
Approximately 15-20 µg total RNA was used for each hybrid-
ization. RNA was visualized by gel electrophoresis to ensure
its integrity before analysis. Biotinylated cRNA was generated
and hybridized to Affymetrix MG_U74Av2 arrays according
to the manufacturer's instructions. To scale between chips,
these expression values were rank ordered, and the median
approximately 96% were averaged. Chips were scaled relative
to each other to equalize this average value. All Affymetrix
control probe sets were eliminated from analysis, yielding
data from a total of 12,422 probe sets. Datasets are publicly
available as CEL files designated MTB_ [1-6] (Additional data
files 3-8 available with the online version of this paper),
2wk_G0P0_ [1-3] (Additional data files 9-11) and
5wk_G0P0_ [1-3] (Additional data files 12-14) containing
results derived from control cohorts, 2-week nulliparous
cohorts, and 5-week nulliparous cohorts respectively.
Algorithms and software
To detect differentially regulated genes, we implemented an
algorithm (ChipStat) that takes identical probe pairs across
two comparison groups and performs a heteroscedastic t-test.
The number of probe pairs within a probe set that are signifi-
cantly different (P  <pps  where  pps  is a fixed value) was
tabulated. We consider that a greater number of probe pairs
changing in a given direction indicates a greater probability
that the gene detected by the probe set is differentially
expressed. If the bulk of the noise within the array data
derives from pre-hybridization experimental factors (that is,
E(b) + E(p); see Results section for definition), the expecta-
tion is that all probe pairs would change coordinately. That is,
if there are 16 probe pairs in the probe set, we would expect
(for E(b) + E(p) >> E(h)) that under the null hypothesis (no
change in gene expression) either 0/16 or 16/16 probe pairs
should change significantly (at frequencies of approximately
1 - pps and approximately pps, respectively). Conversely, if the
bulk of the noise derives from hybridization to individual
probe cells (that is, if E(b) + E(p) << E(h)), then the number
of probe pairs r that change within a given probe set of size t
can be approximated by the binomial distribution:
However, under experimentally realistic conditions, neither
of these limiting cases is likely to apply. Therefore, to empiri-
cally determine the null distribution using six independent,
biologically identical control populations, all pairwise three
by three combinations were compared and the number of
probe pairs changing was tabulated. To determine the
expected number of changes per probe set when fewer than 16
probe pairs are available, these analyses were repeated after
randomly discarding 1, 2...15 probe pairs. In this way, a simi-
lar statistical estimate was obtained for the 602 probe sets on
the MG_U74Av2 array that have fewer than 16 probe pairs
per probe set. A conservative simplification of these data was
performed by rounding up the significance of changes in
these 602 probe sets to the nearest appropriate bin in the 16
probe pair per probe set curve. A Microsoft Windows-com-
patible application implementing the ChipStat algorithm is
freely available for academic use [43].
On the basis of the simplified statistical model described, a
Monte Carlo simulation was implemented to determine the
number of expected false-positive values as a function of pps
for various relative proportions of E(b) + E(p) and E(h).
Briefly, a random test dataset was generated in which equal
gene expression was perturbed by Gaussian noise (represent-
ing E(b) + E(p)). Each expression value was then independ-
ently perturbed 16 times (representing 16 probe pairs/probe
set) by another Gaussian noise function (representing E(h)),
and comparisons were tabulated using the ChipStat algo-
rithm. This simulation was implemented in C and the source
code is available [43]. All values reported reflect the mean of
100 trials, where each trial simulates 11,820 probe sets with
16 probe pairs each. The relative contributions of E(b) + E(p)
and E(h) were estimated by maximizing the likelihood
function:
with respect to (E(b) + E(p)) / E(h) where xi is the number of
times i probe pairs increased significantly and µi and σi repre-
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sent the mean and standard deviation from the Monte Carlo
simulations.
A separate algorithm (Intersector) uses pairwise calls of dif-
ferential gene expression derived from Affymetrix Microarray
Suite (MAS) analysis. All pairwise comparisons were per-
formed (that is, 3 × 3 = 9 comparisons for a 3- vs 3-replicate
comparison) using the manufacturer's default settings, and
the number of 'increases' or 'marginal increases' was tabu-
lated. Similarly to the ChipStat method described above, the
null distribution was generated by tabulating results from all
20 distinguishable 3 vs 3 combinations of the six control sam-
ples. Results were obtained using both MAS version 4 (MAS4)
and MAS version 5 (MAS5), as indicated in the text and
figures.
Tests for differential gene expression using a homoscedastic
t-test or SAM [11] were performed using signal values derived
from MAS5. SAM results were obtained using software
obtained from its authors [44]. Because the analyses
described are reported as a function of the number of genes
expected to increase by chance (essentially a one-tailed test of
significance), the false-discovery rate reported by SAM was
multiplied by 0.5 to derive a corrected false-positive rate
(false-increase rate). dChip analysis [8] was performed using
software available from its authors [45], and a PM-only
expression model was constructed. Logit-T analysis [10] was
performed using software provided by its authors and com-
piled to run locally on an AMD Linux server. Both dChip and
Logit-T significance values were empirically calibrated by
analyzing all possible 3 vs 3 combinations of control arrays
(20 total) and tabulating the average number of false posi-
tives as a function of the reported significance.
Association with biological annotation
Associations between GO [19] annotation and lists of differ-
entially expressed genes were identified using EASE [20].
Multiple testing correction was performed using within-sys-
tem bootstrapping, and a final cutoff of P < 0.05 was used to
identify statistically significant associations.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 contains a table
showing ChipStat and Intersector in combination. For each
level of stringency available, the pairwise intersection of
ChipStat (CS, pps = 0.05) and Intersector (IT, MAS5) lists of
significantly increasing probe sets was generated. Rows
indicate the threshold number of probe pairs (0-16) signifi-
cantly increasing from ChipStat, and columns indicate the
threshold number of Increase or Marginal Increase calls (0-9)
identified by Intersector. (a) Number of increasing probe sets
in 2- vs 5-week murine mammary gland. Selected results cor-
respond to values plotted on the y axis of Figure 4d (number
of probe sets increasing). (b) Average number of increasing
probe sets using all 3 × 3 combinations of 6 negative control
samples. Selected results correspond to values plotted on the
x axis of Figure 4d (expected number of probe sets increasing
by chance). Additional data file 2 contains a table showing dif-
ferential gene expression in 2- vs 5-week murine mammary
gland using a hybrid ChipStat/Intersector approach. The cri-
teria ChipStat pps = 0.05, 6/16 probe pairs increasing and
Intersector 7/9 increases + marginal increases, were used to
identify lists of probe sets that are up- and downregulated
from 2 to 5 weeks of FVB female murine mammary gland
development. Additional data files 3,4,5,6,7 and 8 contain six
control files containing CEL file data from Affymetrix
MG_U74Av2 oligonucleotide microarrays hybridized to RNA
from the third to fifth mammary glands harvested from inde-
pendent pools of three female MTB transgenic mice at 6
weeks 4 days old after 96 hours of doxycycline treatment.
Additional data files 9,10 and 11 contain three CEL files of
data from Affymetrix MG_U74Av2 oligonucleotide microar-
rays hybridized with mammary gland RNA from independent
pools of 10 female FVB mice harvested at 2 weeks of age.
Additional data files 12,13 and 14 contain three CEL files of
data from Affymetrix MG_U74Av2 oligonucleotide microar-
rays hybridized to mammary gland RNA from independent
pools of 10 female FVB mice harvested at 5 weeks of age.
Additional data file 1 A table showing ChipStat and Intersector in combinations A table showing ChipStat and Intersector in combination Click here for additional data file Additional data file 2 A table showing differential gene expression in 2- vs 5-week murine  mammary gland using a hybrid ChipStat/Intersector approach A table showing differential gene expression in 2- vs 5-week murine  mammary gland using a hybrid ChipStat/Intersector approach Click here for additional data file Additional data file 3 Control file 1 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 1 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 4 Control file 2 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 2 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 5 Control file 3 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 3 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 6 Control file 4 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 4 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 7 Control file 5 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 5 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 8 Control file 6 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Control file 6 containing CEL data from Affymetrix MG_U74Av2  oligonucleotide microarrays hybridized to RNA from the third to  fifth mammary glands harvested from independent pools of three  female MTB transgenic mice at 6 weeks 4 days old after 96 hours of  doxycycline treatment Click here for additional data file Additional data file 9 CEL file 1 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age CEL file 1 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age Click here for additional data file Additional data file 10 CEL file 2 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age CEL file 2 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age Click here for additional data file Additional data file 11 CEL file 3 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age CEL file 3 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized with mammary gland RNA from independ- ent pools of 10 female FVB mice harvested at 2 weeks of age Click here for additional data file Additional data file 12 CEL file 1 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age CEL file 1 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age Click here for additional data file Additional data file 13 CEL file 2 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age CEL file 2 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age Click here for additional data file Additional data file 14 CEL file 3 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age CEL file 3 of data from Affymetrix MG_U74Av2 oligonucleotide  microarrays hybridized to mammary gland RNA from independent  pools of 10 female FVB mice harvested at 5 weeks of age Click here for additional data file
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